ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that AIG Hospital in Hyderabad, India, will acquire the ZAP-X® Gyroscopic Radiosurgery® platform. Reinforcing its commitment to patient-centric innovation, AIG Hospitals will become the first hospital in South India to offer this revolutionary brain tumor treatment. This advancement will empower AIG Hospitals’ neurosurgical team to deliver precision-focused care without the need for traditional open surgery, thereby redefining outcomes for patients with brain tumors and other intracranial conditions.
Stereotactic Radiosurgery (SRS), widely accepted as an alternative to conventional brain surgery for many patients, is an incision-free outpatient procedure offering surgical-like precision with no anesthesia, and minimal recovery time. However, access to SRS has remained limited globally due to high infrastructure costs and radiation safety challenges. With ZAP-X, AIG Hospitals addresses these constraints while placing India on the global map of next-generation neurosurgical care.
“At AIG, our unwavering mission has always been to bring the most advanced, evidence-backed, and patient-focused medical technologies to India,” said Dr. D Nageshwar Reddy, Chairman, AIG Hospitals. “The addition of ZAP-X exemplifies this vision. We believe this technology will be a game-changer for patients across India and neighboring regions who can now access world-class radiosurgery without the burden of travel, hospitalization, or surgical recovery.”
Developed by Dr. John R. Adler, former Stanford professor of neurosurgery and radiation oncology, the ZAP-X platform is the world’s first vault-free radiosurgery system, enabling installation without the need for costly radiation-shielded rooms. It also eliminates reliance on traditional Cobalt-60 radioactive sources, using a modern linear accelerator to deliver biologically consistent and efficient radiation doses.
“The strategic investment in ZAP-X is a reflection of our long-term vision to serve as a quaternary referral center for complex neurosurgical care, not only for India but for South-East Asia, the Middle East, and Africa,” said Mr. PVS Raju, Vice-Chairman, AIG Hospitals. “This platform expands our ability to handle high volumes with greater precision, while preserving patient quality of life through non-invasive care.”
Built with a gyroscopic, dual-gimbaled design, ZAP-X offers a large spherical workspace to precisely direct radiation beams from thousands of potential angles and thereby reduce dose concentrations within healthy brain tissue. Along with real-time imaging, ultra-low scatter radiation, and sub-millimeter targeting accuracy, these novel advancements aim to improve outcomes for patients with brain metastases, meningiomas, acoustic neuromas, arteriovenous malformations, and trigeminal neuralgia.
At the heart of this development lies AIG’s Neurosurgical Program, led by Dr. Subodh Raju, Director & HOD, Neurosurgery, whose team will spearhead the clinical deployment of ZAP-X.
“ZAP-X is not just a technological upgrade, it is a paradigm shift,” said Dr. Subodh Raju. “It enables us to precisely target even the most complex lesions while sparing healthy brain tissue. Patients walk in, undergo the pain-free session in a day-care setup, and walk out without hospitalization, or post-op recovery. This is the future of brain tumor treatment, and it will be now available in Hyderabad.”
He added, “The ability to offer repeat treatments when needed, patient-friendly immobilization without the rigid head frames of the past, and real-time dose monitoring puts this system at the forefront of radiosurgical safety and patient comfort.”
With ZAP-X, AIG Hospitals strengthens its position as a neuroscience leader and becomes part of an elite global network of early adopters of this technology. This move aligns with the hospital’s larger vision to bridge the gap between cutting-edge research and clinical practice while ensuring equitable access to life-saving innovations.